ClinicalTrials.gg
Active, not recruitingNCT06084390Updated Aug 20, 2026

Interdisciplinary Rehabilitation for Chronic Pain in Primary Healthcare

An interventional study of Interdisciplinary care + booster session (intervention) and Interdisciplinary care (control) in Chronic Pain and Pain Management, sponsored by Vastra Gotaland Region. Active, not recruiting at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-20.

Sponsored by Vastra Gotaland Region · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 88 studies in Chronic Pain with a site in Sweden — 30 open to participants now, 37 under way, none of them phase 3. Chronic Pain · Sweden.

Planned enrollment
10th of 65
200 · median 80
Started
2023
with 2 others
No phase
61 of 88
23 open now
Primary completion
2026-12
later than 13 of 36 live
Registered
62nd of 88
by date
Lead sponsor
4 of 88
Vastra Gotaland Region

Among the 88 studies in Chronic Pain with a site in Sweden, this one is the 10th largest by planned enrollment of the 65 interventional ones that give a count, is one of 3 that started in 2023, is one of 61 with no phase, reaches primary completion later than 13 of the 36 other live ones, and was the 62nd registered.

Chronic Pain

3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.

Browse Chronic Pain studies →

Open to participants now

30 of the 88 studies in Chronic Pain with a site in Sweden are open now. Recruiting first, the newest first:

25 more — sign in →

All 30 open studies →

A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →

Who these studies take

Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 88 studies in Chronic Pain with a site in Sweden, or all of them as a file.
02

Study summary

Purpose: The overall aim is to investigate the effect of interdisciplinary rehabilitation in primary health care (PHC) for patients with chronic pain. Specific questions: What is the effect of extended access to the interdisciplinary PHC pain team + a booster session after finishing the rehabilitation program? Does participation in PHC interdisciplinary rehabilitation contribute to health improvements and are there predictors of this? Method: A randomized controlled trial (RCT). 200 patients with chronic pain that participate in interdisciplinary rehabilitation in primary healthcare in Region Västra Götaland (VGR) in Sweden will be included in the RCT and randomized to Intervention; standard care by the interdisciplinary teams in PHC + extended access to the team and a booster session 3 months after the end of the rehabilitation, or Control; only standard care by the interdisciplinary teams. Outcomes are health related quality of life, pain intensity and other health aspects.

Read the detailed description

The participants will be randomly allocated to intervention or active control. All participants in both arms receive the standard care for interdisciplinary rehabilitation at any of the six PHC pain teams in VGR. The teams consist of a physician, physiotherapist, occupational therapist and psychologist. All teams provide person-centred rehabilitation, aiming to increase physical activity and support behavioural changes, and to decrease symptoms and the impact of pain on the patients´ daily lives. The standard care interdisciplinary rehabilitation period contains both theoretical and practical components such as patient education, physical exercise and behavioural interventions. The sessions are mainly group-based. The duration of the rehabilitation period varies between 5 to 7 weeks + a follow-up visit after 3 months.

The participants in the intervention arm also receive an extra booster-session 3 months after the standard follow-up. At the booster-session, the participant´s individual rehabilitation plan is followed-up and adjusted. This extra period also includes extended access to the team, meaning that the participants have the possibility to contact the team and, if needed, have digital or telephone contact.

The participants complete a battery of questionaires included in the Swedish Quality Registry for Pain Rehabilitation an also extra questionnaires provided to the participants through an electronic research form.

Data collection is made at baseline before starting the rehabilitation, directly after the 5 to 7 weeks rehabilitation period and 6, 12 and 24 months after baseline.

03

Conditions studied

  • Chronic Pain
  • Pain Management

Browse trials for

Keywords

  • randomised controlled trial
  • primary care
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Persons participating in interdisciplinary team rehabilitation in primary healthcare in Region Västra Götaland, Sweden.

Exclusion criteria

Exclusion Criteria:

  • Severe psychiatric disease, language difficulties that makes it impossible to complete the questionnaires
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Interdisciplinary rehabilitation + booster-session (intervention)

    Standard care by the interdisciplinary rehabilitation teams in primary healthcare + extended access to the team and a booster visit after 3 months.

    Other: Interdisciplinary care + booster session (intervention)

  • Active comparator
    Interdisciplinary rehabilitation (control)

    Standard care by the interdisciplinary rehabilitation teams in primary healthcare.

    Other: Interdisciplinary care (control)

Interventions

  • OtherInterdisciplinary care + booster session (intervention)

    Standard care for interdisciplinary rehabilitation at any of the six interdisciplinary teams in primary health care in Region Västra Götaland, Sweden + one extra booster-session 3 months after the standard care rehabilitation. At the booster-session, the participant´s individual rehabilitation plan is followed-up and adjusted. This extra period also includes extended access to the team, meaning that the participants have the possibility to contact the team and, if needed, have digital or telephone contact.

  • OtherInterdisciplinary care (control)

    Standard care for interdisciplinary rehabilitation at any of the six interdisciplinary teams in primary health care in Region Västra Götaland, Sweden.

06

What researchers measure

Primary outcomes

  1. Pain intensity

    Assessed with visual analog scale and numeric rating scale (0-100 mm, higher is more severe pain)

    Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.

  2. Health related quality of life

    Rand-36 (0-100, a higher score indicates better health-related quality of life)

    Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.

  3. Health related quality of life 2

    EuroQol 5D-3L (0-100, a higher score indicates better health-related quality of life)

    Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.

  4. Health related quality of life 3

    EuroQol-Visual analogue scale (0-100, a higher score indicates better health-related quality of life)

    Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.

Secondary outcomes

  1. Pain spread

    The participants mark in boxes painful areas

    Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.

  2. Pain acceptance

    The Chronic pain acceptance questionnaire (CPAQ-8) (Total score 0-48, 2 subscales 0-24 p. Higher score means better pain acceptance)

    Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.

  3. Self-efficacy

    The Pain self-efficacy questionnaire short-form (PSEQ\_2) (0-12, a higher score means better self-efficacy)

    Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from from the end of the rehabilitation period.

  4. Symptoms of stress

    The stress and crisis inventory (SCI-93) (0-140, a higher score means more stress) symptoms)

    Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.

  5. Physical activity

    The Godin questionnaire (hours of physical activity per week)

    Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.

  6. Anxiety and depression

    The hospital anxiety and depression scale (2 subscales for symptoms of anxiety and depression ranging from 0 to 21, a higher value means a higher degree of anxiety or depression)

    Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.

  7. Self-rated function

    The Functional rating index (0-100 %, higher percent is worse)

    Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.

  8. Work ability

    One question (number 7) from the Work ability index (0-10, higher score is better)

    Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.

  9. Life satisfaction

    The LiSat questionnaire (2 questions ranging 1-6, higher score is better life satisfaction)

    Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.

  10. Fatigue

    The multidimensional fatigue inventory (5 subscales ranging from 4 -20, higher score means more fatigue)

    Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.

  11. Pain catastrophizing

    The pain catastrophizing scale (Total score 0-52, higher score is worse)

    Time frame: Baseline, directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.

  12. Patients´ own impression of change

    Patient global impression of change (1-7, lower score means more improvement)

    Time frame: Directly after the rehabilitation period and 6, 12 and 24 months from the end of the rehabilitation period.

  13. Health care use

    Health care visit statistics

    Time frame: From 12 months before to 24 months after the rehabilitation period.

  14. Sickness abscence

    Sickness absence data

    Time frame: From 12 months before to 24 months after the rehabilitation period.

07

Study locations

1 site
  • Research and development primary health care Fyrbodal
    Vänersborg, Region Västra Götaland 46235, Sweden
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2023 (actual). Primary completion is estimated for Dec 2026, 38 months after the start.

Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's planned 38 months is above that.

Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 10, 2023
First posted
Oct 16, 2023
StartActual
Oct 13, 2023
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Aug 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06084390
Responsible party
Sponsor
First posted
Oct 16, 2023
Start date
Oct 13, 2023
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Aug 20, 2026

Study contacts

Anna Bergenheim, Dr
principal investigator · Research and development primary healthcare Fyrbodal, region Västra Götaland, Sweden

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion